These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 23498161)

  • 41. Peritubular capillary C4d deposition and renal outcome in post-transplant IgA nephropathy.
    Choi J; Cho YM; Yang WS; Park TJ; Chang JW; Park SK
    Clin Transplant; 2007; 21(2):159-65. PubMed ID: 17425739
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Complement fragment C4d and C3d deposition in pediatric heart recipients with a positive crossmatch.
    Holt DB; Liapis H; Mohanakumar T; Phelan DR; Gandi SK; Huddleston CB; Canter CE
    J Heart Lung Transplant; 2008 Oct; 27(10):1073-8. PubMed ID: 18926396
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prevalence of C4d-positive renal allografts in 134 consecutive biopsies in Thai patients.
    Cheunsuchon B; Vongwiwatana A; Premasathian N; Shayakul C; Parichatikanond P
    Transplant Proc; 2009 Nov; 41(9):3697-700. PubMed ID: 19917370
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Analysis of different staining techniques for c4d detection in renal allograft biopsies.
    Ludovico-Martins H; Silva C; Teodoro WR; Martini Filho D; Noronha IL
    Transplant Proc; 2009 Apr; 41(3):862-5. PubMed ID: 19376373
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Transplant glomerulopathy may occur in the absence of donor-specific antibody and C4d staining.
    Akalin E; Dinavahi R; Dikman S; de Boccardo G; Friedlander R; Schroppel B; Sehgal V; Bromberg JS; Heeger P; Murphy B
    Clin J Am Soc Nephrol; 2007 Nov; 2(6):1261-7. PubMed ID: 17942771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. C4d staining of pulmonary allograft biopsies: an immunoperoxidase study.
    Wallace WD; Reed EF; Ross D; Lassman CR; Fishbein MC
    J Heart Lung Transplant; 2005 Oct; 24(10):1565-70. PubMed ID: 16210131
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Solid phase detection of C4d-fixing HLA antibodies to predict rejection in high immunological risk kidney transplant recipients.
    Bartel G; Wahrmann M; Schwaiger E; Kikić Ž; Winzer C; Hörl WH; Mühlbacher F; Hoke M; Zlabinger GJ; Regele H; Böhmig GA
    Transpl Int; 2013 Feb; 26(2):121-30. PubMed ID: 23145861
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Late antibody-mediated rejection after heart transplantation: Mortality, graft function, and fulminant cardiac allograft vasculopathy.
    Coutance G; Ouldamar S; Rouvier P; Saheb S; Suberbielle C; Bréchot N; Hariri S; Lebreton G; Leprince P; Varnous S
    J Heart Lung Transplant; 2015 Aug; 34(8):1050-7. PubMed ID: 25956740
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Molecular Assessment of Microcirculation Injury in Formalin-Fixed Human Cardiac Allograft Biopsies With Antibody-Mediated Rejection.
    Afzali B; Chapman E; Racapé M; Adam B; Bruneval P; Gil F; Kim D; Hidalgo L; Campbell P; Sis B; Duong Van Huyen JP; Mengel M
    Am J Transplant; 2017 Feb; 17(2):496-505. PubMed ID: 27401781
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Asymptomatic antibody-mediated rejection after heart transplantation predicts poor outcomes.
    Wu GW; Kobashigawa JA; Fishbein MC; Patel JK; Kittleson MM; Reed EF; Kiyosaki KK; Ardehali A
    J Heart Lung Transplant; 2009 May; 28(5):417-22. PubMed ID: 19416767
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical relevance of complement-fixing antibodies in cardiac transplantation.
    Rose ML; Smith JD
    Hum Immunol; 2009 Aug; 70(8):605-9. PubMed ID: 19375471
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Glomerular C3c deposition and intravascular macrophage accumulation in early humoral renal allograft rejection signifies a poor short-term outcome.
    Mölne J; Nyberg G; Blohmé I; Rydberg L; Breimer ME; Svalander CT
    APMIS; 2006 Oct; 114(10):700-11. PubMed ID: 17004973
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A comparative analysis between survivors and nonsurvivors with antibody mediated cardiac allograft rejection.
    Gonzalez-Stawinski GV; Cook DJ; Chui J; Gupta S; Navia JL; Hoercher K; Taylor DO; Yamani MH; Starling RC; Smedira NG
    J Surg Res; 2007 Oct; 142(2):233-8. PubMed ID: 17727888
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sinusoidal C4d deposits in liver allografts indicate an antibody-mediated response: diagnostic considerations in the evaluation of liver allografts.
    Kozlowski T; Andreoni K; Schmitz J; Hayashi PH; Nickeleit V
    Liver Transpl; 2012 Jun; 18(6):641-58. PubMed ID: 22298469
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Donor-specific antibodies are associated with antibody-mediated rejection, acute cellular rejection, bronchiolitis obliterans syndrome, and cystic fibrosis after lung transplantation.
    Lobo LJ; Aris RM; Schmitz J; Neuringer IP
    J Heart Lung Transplant; 2013 Jan; 32(1):70-7. PubMed ID: 23260706
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Limited utility of endomyocardial biopsy in the first year after heart transplantation.
    Hamour IM; Burke MM; Bell AD; Panicker MG; Banerjee R; Banner NR
    Transplantation; 2008 Apr; 85(7):969-74. PubMed ID: 18408576
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibody Mediated Rejection is not Associated with Worse Survival in Adherent Heart Transplant Patients in the Contemporary Era.
    Kim PJ; Cusi V; Cardenas A; Tada Y; Vaida F; Wettersten N; Chak J; Bijlani P; Pretorius V; Urey MA; Morris GP; Lin G
    medRxiv; 2023 Dec; ():. PubMed ID: 38106112
    [TBL] [Abstract][Full Text] [Related]  

  • 58. C4d-the witness of humoral rejection.
    de Gouveia RH; Vitorino E; Ramos S; Rebocho MJ; Queirós E Melo J; Martins AP; Moura ML
    Transplant Proc; 2009 Apr; 41(3):866-7. PubMed ID: 19376374
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Very late heart transplant rejection is associated with microvascular injury, complement deposition and progression to cardiac allograft vasculopathy.
    Loupy A; Cazes A; Guillemain R; Amrein C; Hedjoudje A; Tible M; Pezzella V; Fabiani JN; Suberbielle C; Nochy D; Hill GS; Empana JP; Jouven X; Bruneval P; Duong Van Huyen JP
    Am J Transplant; 2011 Jul; 11(7):1478-87. PubMed ID: 21668629
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The clinical and molecular significance of C4d staining patterns in renal allografts.
    Hayde N; Bao Y; Pullman J; Ye B; Calder BR; Chung M; Schwartz D; Alansari A; de Boccardo G; Ling M; Akalin E
    Transplantation; 2013 Feb; 95(4):580-8. PubMed ID: 23274969
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.